AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol (November 28, 2007). doi:10.1152/ajpregu.00481.2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/2/R421    most recent
00481.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stegbauer, J.
Right arrow Articles by Rump, L. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stegbauer, J.
Right arrow Articles by Rump, L. C.
Submitted on July 4, 2007
Accepted on November 22, 2007

Endothelial nitric oxide synthase is predominantly involved in Angiotensin II modulation of renal vascular resistance and norepinephrine release

Johannes Stegbauer1, Yvonne Kuczka1, Oliver Vonend2, Ivo Quack1, Lorenz Sellin3, Andreas Patzak4, Andreas Steege4, Kristina Langnaese5, and Lars Christian Rump3*

1 Medizinische Klinik I, Marienhospital Herne, Ruhr-University Bochum, Herne, Germany
2 Medizinische Klinik I, Marienhospital Herne, Ruhr-University Bochum, Bochum, Germany
3 Department of Nephrology, Heinrich-Heine-University, Dusseldorf, Germany
4 Herz-Kreislauf-Physiologie, University-Hospital Charite, Berlin, Germany
5 Medical Faculty, Institute for Medical Neurobiology, Magdeburg, Germany

* To whom correspondence should be addressed. E-mail: christian.rump{at}rub.de.

NO is mainly generated by endothelial nitric oxide synthase (eNOS) or neuronal nitric oxide synthase (nNOS). Recent studies indicate that Ang II generates NO release, which modulates renal vascular resistance and sympathetic neurotransmission. Experiments in wild-type [eNOS(+/+) and nNOS(+/+)], eNOS deficient [eNOS(-/-)] and nNOS decficient [nNOS(-/-)] mice were performed to determine which NOS isoform is involved. Isolated mice kidneys were perfused with Krebs-Henseleit solution. Endogenous norepinephrine (NE) release was measured by HPLC. Ang II dose dependently increased renal vascular resistance in all mice species. EC50 and maximal pressor responses to Ang II were greater in eNOS(-/-) than in nNOS(-/-) and smaller in wild type (WT) mice. The non-selective NOS inhibitor L-NAME (0.3mM) enhanced Ang II induced pressor responses in nNOS(-/-) and WT but not in eNOS(-/-) mice. In nNOS(+/+) mice 7-nitroindazole monosodium salt (0.3mM), a selective nNOS inhibitor, enhanced Ang II induced pressor responses slightly. Ang II enhanced renal nerve stimulation induced NE release in all species. L-NAME (0.3mM) reduced Ang II mediated facilitation of NE release in nNOS(-/-) and WT but not in eNOS(-/-) mice. 7-NINA failed to modulate NE release in nNOS(+/+) mice. 8-cPTC-cGMP (0.1nM) increased NE release. mRNA expression of eNOS, nNOS and iNOS did not differ between mice strains. In conclusion, Ang II mediated effects on renal vascular resistance and sympathetic neurotransmission are modulated by NO in mice. These effects are mediated by eNOS and nNOS, but NO derived from eNOS dominates. Only NO derived from eNOS seems to modulate Ang II mediated renal NE release.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.